These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12948007)

  • 1. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.
    Li Q; Sai Y; Kato Y; Tamai I; Tsuji A
    Pharm Res; 2003 Aug; 20(8):1119-24. PubMed ID: 12948007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
    Pfrunder A; Gutmann H; Beglinger C; Drewe J
    J Pharm Pharmacol; 2003 Jan; 55(1):59-66. PubMed ID: 12625868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
    Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
    Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180.
    Aiba T; Susa M; Fukumori S; Hashimoto Y
    Drug Metab Pharmacokinet; 2005 Aug; 20(4):268-74. PubMed ID: 16141606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
    Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
    J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.
    Nakamura T; Sakaeda T; Ohmoto N; Tamura T; Aoyama N; Shirakawa T; Kamigaki T; Nakamura T; Kim KI; Kim SR; Kuroda Y; Matsuo M; Kasuga M; Okumura K
    Drug Metab Dispos; 2002 Jan; 30(1):4-6. PubMed ID: 11744604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
    Giessmann T; May K; Modess C; Wegner D; Hecker U; Zschiesche M; Dazert P; Grube M; Schroeder E; Warzok R; Cascorbi I; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2004 Sep; 76(3):192-200. PubMed ID: 15371980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routes.
    Tavelin S; Taipalensuu J; Hallböök F; Vellonen KS; Moore V; Artursson P
    Pharm Res; 2003 Mar; 20(3):373-81. PubMed ID: 12669956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Cummins CL; Mangravite LM; Benet LZ
    Pharm Res; 2001 Aug; 18(8):1102-9. PubMed ID: 11587480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.
    Becquemont L; Glaeser H; Drescher S; Hitzl M; Simon N; Murdter TE; Heinkele G; Hofmann U; Schaefer C; Burk O; Verstuyft C; Eichelbaum M; Fromm MF
    Clin Pharmacol Ther; 2006 May; 79(5):449-60. PubMed ID: 16678547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies.
    Engman HA; Lennernäs H; Taipalensuu J; Otter C; Leidvik B; Artursson P
    J Pharm Sci; 2001 Nov; 90(11):1736-51. PubMed ID: 11745731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
    Behrens I; Kissel T
    Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
    Patel J; Buddha B; Dey S; Pal D; Mitra AK
    Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of budesonide on P-glycoprotein expression in intestinal cell lines.
    Maier A; Zimmermann C; Beglinger C; Drewe J; Gutmann H
    Br J Pharmacol; 2007 Feb; 150(3):361-8. PubMed ID: 17179942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericum perforatum: which constituents may induce intestinal MDR1 and CYP3A4 mRNA expression?
    Gutmann H; Poller B; Büter KB; Pfrunder A; Schaffner W; Drewe J
    Planta Med; 2006 Jun; 72(8):685-90. PubMed ID: 16755466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
    Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
    Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells.
    Seithel A; Karlsson J; Hilgendorf C; Björquist A; Ungell AL
    Eur J Pharm Sci; 2006 Jul; 28(4):291-9. PubMed ID: 16704924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification.
    Chan LM; Cooper AE; Dudley AL; Ford D; Hirst BH
    J Drug Target; 2004; 12(7):405-13. PubMed ID: 15621665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Curcuma extracts and curcuminoids on expression of P-glycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180.
    Graber-Maier A; Büter KB; Aeschlimann J; Bittel C; Kreuter M; Drewe J; Gutmann H
    Planta Med; 2010 Nov; 76(16):1866-70. PubMed ID: 20509107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.